A Sustained Reduction in IκB-β May Contribute to Persistent NF-κB Activation in Human Endothelial Cells
Open Access
- 1 July 1996
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (27) , 16317-16322
- https://doi.org/10.1074/jbc.271.27.16317
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- NF-κB: A lesson in family valuesCell, 1995
- IκB-β regulates the persistent response in a biphasic activation of NF-κBCell, 1995
- Synergistic activation of intercellular adhesion molecule 1 (ICAM‐1) by TNF‐α and IFN‐γ is mediated by p65/p50 and p65/c‐Rel and interferon‐responsive factor Statlα (p91) that can be activated by both IFN‐γ and IFN‐αFEBS Letters, 1994
- Regulation of the NF-ηB/rel transcription factor and IηB inhibitor systemCurrent Opinion in Cell Biology, 1993
- KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.The Journal of Experimental Medicine, 1993
- The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimersCell, 1993
- The High Mobility Group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β geneCell, 1992
- Tumor necrosis factor-α, interleukin 1, and phorbol myristate acetate are independent activators of NF-κB which differentially activate T cellsCytokine, 1991
- Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"Nature, 1990
- NF-κB: A pleiotropic mediator of inducible and tissue-specific gene controlCell, 1989